肝硬化门静脉血栓形成的危险因素

阮芳鸣; 李弼民

doi:10.3969/j.issn.1001-5256.2020.01.043

肝硬化门静脉血栓形成的危险因素

DOI: 10.3969/j.issn.1001-5256.2020.01.043

南昌大学第一附属医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 948
- HTML全文浏览量: 45
- PDF下载量: 211
- 被引次数: 0
出版历程
- 收稿日期: 2019-09-01
- 出版日期: 2020-01-20

Risk factors for the formation of portal vein thrombosis in patients with liver cirrhosis

Department of Gastroenterology,the First Affiliated Hospital of Nanchang University

摘要

摘要: 门静脉血栓(PVT)在肝硬化患者中较常见,合并PVT的静脉曲张更容易出血,止血失败率及再出血率更高,对于肝移植患者,其预后更差。目前PVT形成的相关危险因素较多,如肝功能严重程度、非选择性β受体阻滞剂的使用、门静脉血流速度等。重点对肝硬化PVT形成的危险因素进行综述,以进一步了解PVT形成的相关机制和PVT的危险程度。
- 门静脉血栓 /
- 肝硬化 /
- 危险因素
Abstract: Portal vein thrombosis(PVT) is commonly seen in patients with liver cirrhosis. Patients with varices complicated by portal vein thrombosis are more likely to experience bleeding,with higher failure rate of hemostasis and rebleeding rate,and the patients receiving liver transplantation may have a poorer prognosis. There are various risk factors for portal vein thrombosis,such as severity of liver dysfunction,use of non-selective beta blockers,and portal vein blood flow velocity. This article reviews the risk factors for portal vein thrombosis in patients with liver cirrhosis,in order to further understand the mechanism and risk level of portal vein thrombosis.
- portal vein thrombosis /
- liver cirrhosis /
- risk factors

HTML全文

参考文献(47)

[1] JANSSE N. Changing perspectives in portal vein thrombosis[J]. Scand J Gastroenterol Suppl,2000,232:69-73.

[2] JANSSEN H,WIJNHOUD A,HAAGSMA E,et al. Extrahepatic portal vein thrombosis:Aetiology and determinants of survival[J]. Gut,2001,49(5):720-724.

[3] FIMOGNARI F,VIOLI F. Portal vein thrombosis in liver cirrhosis[J]. Intern Emerg Med,2008,3(3):213-2138.

[4] VIOLI F,CORAZZA G,CALDWELL S,et al. Portal vein thrombosis relevance on liver cirrhosis:Italian venous thrombotic events Registry[J]. Intern Emerg Med,2016,11(8):1059-1066.

[5] NONAMI T,YOKOYAMA I,IWATSUKI S,et al. The incidence of portal vein thrombosis at liver transplantation[J]. Hepatology,1992,16(5):1195-1198.

[6] PELLICELLI A,AMBROSIO D,BABARO G,et al. Clinical and genetic factors associated to development of portal vein thrombosis in cirrhotic patients without hepatocellular carcinoma[J].J Hepatol,2011,54:s77-s77

[7] ZOCCO M,DISTASIO E,CRISTOFARO R,et al. Thrombotic risk factors in patients with liver cirrhosis:Correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol,2009,51(4):682-689.

[8] ABDEL R,MOUSA N,ELHELALY R,et al. De-novo portal vein thrombosis in liver cirrhosis:Risk factors and correlation with the Model for End-stage Liver Disease scoring system[J]. Eur J Gastroenterol Hepatol,2015,27(5):585-592.

[9] WESTABY D,BIHARI D,GIMSON A,et al. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension[J].Gut,1984,25(2):121-124.

[10] ZOLI M,MARCHESINI G,BRUNORI A,et al. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis[J]. Hepatology,1986,6(6):1248-1251.

[11] QI XS,BAI M,FAN DM,Nonselective beta-blockers may induce development of portal vein thrombosis in cirrhosis[J].World J Gastroenterol,2014,20(32):11463-11466.

[12] ZAMPINO R,LEBANO R,COPPOLA N,et al. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients[J]. Saudi J Gastroenterol,2018,24(1):25-29.

[13] NERY F,CORREIA S,MACEDO C,et al. Nonselective betablockers and the risk of portal vein thrombosis in patients with cirrhosis:Results of a prospective longitudinal study[J]. Aliment Pharmacol Ther,2019,49(5):582-588.

[14] XU XB,GUO XZ,STEFANO V,et al. Nonselective betablockers and development of portal vein thrombosis in liver cirrhosis:A systematic review and Meta-analysis[J]. Hepatol Int,2019,13(4):468-481.

[15] ZIRONI G,GAIANI S,FENYVES D,et al. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension[J]. J Hepatol,1992,16(3):298-303.

[16] STINE J,WANG J,SHAH P,et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis:A matched case-control study[J]. Liver Int,2018,38(1):94-101.

[17] AYALA R,GRANDE S,BUSTELOS R,et al. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients[J]. BMC Gastroenterol,2012,12:114.

[18] STINE J,SHAH N,ARGO C,et al. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis[J]. Liver Transpl,2015,21(8):1016-1021.

[19] STINE J,ARGO C,PELLETIER S,et al. Advanced non-alcoholic steatohepatitis cirrhosis:A high-risk population for pre-liver transplant portal vein thrombosis[J]. World J Hepatol,2017,9(3):139-146.

[20] TRIPODI A,FRACANZANI A,CHANTARANGKUL V,et al.Procoagulant imbalance in patients with non-alcoholic fatty liver disease[J]. J Hepatol,2017,66(1):248-250.

[21] HERNANDEZ M,LLOP E,FERNANDEZ C,et al. Visceral fat is associated with cirrhotic portal vein thrombosis[J]. Expert Rev Gastroenterol Hepatol,2019,13(10):1017-1022..

[22] POORT S,ROSENDAAL F,REITSMA P,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis[J]. Blood,1996,88(10):3698-3703.

[23] AMITRANO L,GUARDASCIONE M,BRANCACCIO V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J]. J Hepatol,2004,40(5):736-741.

[24] AMITRANO L,GUARDASCIONE M,AMES P,et al. Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation[J].Thromb Haemost,2006,95(2):221-223.

[25] BERTINA R,KOELEMAN B,KOSTER T,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C[J]. Nature,1994,369(6475):64-67.

[26] AMITRANO L,BRANCACCIO V,GUARDASCIONE M,et al.Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis[J]. Hepatology,2000,31(2):345-348.

[27] ERKAN O,BOZDAYI A,DISIBEYAZ S,et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis[J]. Eur J Gastroenterol Hepatol,2005,17(3):339-343.

[28] QI XS,REN WR,STEFANO V,et al. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis:A systematic review and Meta-analysis[J]. Clin Gastroenterol Hepatol,2014,12(11):1801-1812. e7.

[29] MARUYAMA H,OKUGAWA H,TAKAHASHI M,et al. De novo portal vein thrombosis in virus-related cirrhosis:Predictive factors and long-term outcomes[J]. Am J Gastroenterol,2013,108(4):568-574.

[30] ASHIDA H,KOTOURA Y,NISHIOKA A,et al. Portal and mesenteric venous thrombosis as a complication of endoscopic sclerotherapy[J]. Am J Gastroenterol,1989,84(3):306-310.

[31] BARSOUM M,MOORO A,BOLOUS F,et al. The complications of injection sclerotherapy of bleeding oesophageal varices[J]. Br J Surg,1982,69(2):79-81.

[32] KORULA J,YELLIN A,KANEL G,et al. Portal vein thrombosis complicating endoscopic variceal sclerotherapy. Convincing further evidence[J]. Dig Dis Sci,1991,36(8):1164-1167.

[33] POLITOSKE D,RALLS P,KORULA J,Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis[J]. Dig Dis Sci,1996,41(1):185-190.

[34] AMITRANO L,BRANCACCIO V,GUARDASCIONE M,et al.Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients:Role of genetic thrombophilia[J]. Endoscopy,2002,34(7):535-538.

[35] QI XS,LI HY,LIU X,et al. Novel insights into the development of portal vein thrombosis in cirrhosis patients[J]. Expert Rev Gastroenterol Hepatol,2015,9(11):1421-1432.

[36] QI XS,HAN G,YE C,et al. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J]. Med Sci Monit,2016,22:2528-5250.

[37] ZHANG X,WANG Y,YU M,et al. Effective prevention for portal venous system thrombosis after splenectomy:A Metaanalysis[J]. J Laparoendosc Adv Surg Tech A,2017,27(3):247-252.

[38] WU J,SHEN M,ZHANG Y,et al. Value of CT/MRI in predicting portal vein thrombosis in patients with hepatic fibrosis/cirrhosis after splenectomy[J/CD]. Chin J Hepatic Surg(Electronic Edition),2018,7(3):231-235.(in Chinese)吴珺，沈敏，张瑶，等．CT/MRI在预测肝纤维化/肝硬化脾切除术后门静脉血栓形成中的价值[J/CD]．中华肝脏外科手术学电子杂志，2018,7(3):231-235.

[39] DUFFY J,HONG J,FARMER D,et al. Vascular complications of orthotopic liver transplantation:Experience in more than 4,200 patients[J]. J Am Coll Surg,2009,208(5):896-903;discussion 903-905.

[40] LLADO L,FABREGAT J,CASTELLOTE J,et al. Management of portal vein thrombosis in liver transplantation:Influence on morbidity and mortality[J]. Clin Transplant,2007,21(6):716-721.

[41] XUE Z,ZHANG X. Analysis of portal vein thrombosis after liver transplantation[J]. ANZ J Surg,2019,89(9):1075-1079.

[42] JIA Y,LU Q,GONG S,et al. Postoperative complications in patients with portal vein thrombosis after liver transplantation:Evaluation with Doppler ultrasonography[J]. World J Gastroenterol,2007,13(34):4636-4640.

[43] FOLSOM A,LUTSEY P,HECKBERT S,et al. Serum albumin and risk of venous thromboembolism[J]. Thromb Haemost,2010,104(1):100-104.

[44] BASILI S,CARNEVALE R,NOCELLA C,et al. Serum albumin is inversely associated with portal vein thrombosis in cirrhosis[J]. Hepatol Commun,2019,3(4):504-512.

[45] TRIPODI A,PRIMIGNANI M,CHANTARANGKUL V,et al. An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis[J]. Gastroenterology,2009,137(6):2105-2111.

[46] CHEN H,QI X,HE C,et al,Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis[J]. Thromb Res,2013,131(2):173-177.

[47] TANG W,WANG Y,ZHAO X,et al. Procoagulant imbalance aggravated with falling liver function reserve,but not associated with the presence of portal vein thrombosis in cirrhosis[J].Eur J Gastroenterol Hepatol,2015,27(6):672-678.

施引文献

资源附件(0)

访问统计